FDA Approves Seroquel As Add-On Treatment For Depression
News broke late last night that AstraZeneca announced that hte FDA has approved Seroquel XR, an atypical antipsychotic, as an add-on treatment for depression. It’s been eight months since an FDA panel very gingerly recommended this approval and the agency took an unusually long time to follow through. That should tell you something. The FDA made a bad choice here.
Good luck to patients with the weight gain, diabetes, heart problems, muscle tightening, dead in the head feeling and back pain.
Can’t wait to see if AZ advertises Seroquel on TV.
Related posts:
- Seroquel Promoted As Weight Neutral When Company Knew It Produced Large Weight Gain
- AstraZeneca Defends Seroquel Weight Gain Warnings
- AstraZeneca Exec Was Pressed To Lie About Seroquel Weight Gain
- AstraZeneca Denied Seroquel Diabetes Link After Warning Of It In Japan
- AstraZeneca Can’t Exclude Diabetes Expert Witness From Seroquel Trials
Posted in Furious Seasons